On July 1st, 2017, the glycerin fructose“re-listing”seminar held by Hainan Melexang Pharmaceutical was successfully held in Beijing. The conference was attended by investment managers and product managers from all over the country. The meeting focused on analyzing product features. Pushing "Chen" out "new", brain products "new" choice, grasping the market pulse, reviewing "time" degree "potential", glycerol fructose "re-" listing two major themes, on the new ideas of the promotion of glycerol fructose Discussion, the meeting responded enthusiastically, and achieved good results, but also made a good start for the future academic promotion and investment promotion of glycerol fructose across the country. In the future, Mellon Pharmaceuticals will also pay more attention to academic promotion and cooperation with various regions, seek common development and work together to win the future.
Marketing Manager Ms. Yang Ying Academic Report on Cerebrovascular Disease and Glycerol Fructose
Marketing Department Product Manager Mr. Yang Yang analyzes the product features,
pushes“Chen”out“new”, and brain products“new”choice ideas to share.
Mr. Xie Yongliang, National Sales Director of Melokang Pharmaceuticals,
took the pulse of the market, reviewed the“time”degree, and reported the theme of“Glycerin”
Interactive session of the meeting
Mr. Li Chunya, General Manager of Hainan Melexang Pharmaceutical Co., Ltd.
Mr. Fang Yisheng, Chairman of the Group, and the participants